{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:32:07Z","timestamp":1792290727684,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41401-020-0401-y","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:02:37Z","timestamp":1591340557000},"page":"55-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPAR\u03b1\/PGC-1 pathway"],"prefix":"10.1038","volume":"42","author":[{"given":"Ning","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-ai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-chang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan-jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-feng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-xuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"401_CR1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/eurheartj\/ehm296","volume":"28","author":"P Collins","year":"2007","unstructured":"Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J. 2007;28:2028\u201340.","journal-title":"Eur Heart J"},{"key":"401_CR2","doi-asserted-by":"crossref","first-page":"E1606","DOI":"10.1152\/ajpendo.00246.2007","volume":"293","author":"MS Bhuiyan","year":"2007","unstructured":"Bhuiyan MS, Shioda N, Fukunaga K. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am J Physiol Endocrinol Metab. 2007;293:E1606\u201314.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"401_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heartjnl-2015-308287","volume":"102","author":"H Boardman","year":"2016","unstructured":"Boardman H, Hartley L, Eisinga A, Main C, Figuls MR. Cochrane corner: oral hormone therapy and cardiovascular outcomes in post-menopausal women. Heart. 2016;102:9\u201311.","journal-title":"Heart"},{"key":"401_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","volume":"117","author":"T Kamo","year":"2015","unstructured":"Kamo T, Akazawa H, Komuro I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res. 2015;117:89\u201398.","journal-title":"Circ Res"},{"key":"401_CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11906-004-0036-2","volume":"6","author":"MF Allard","year":"2004","unstructured":"Allard MF. Energy substrate metabolism in cardiac hypertrophy. Curr Hypertens Rep. 2004;6:430\u20135.","journal-title":"Curr Hypertens Rep"},{"key":"401_CR6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","volume":"114","author":"T Oka","year":"2014","unstructured":"Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res. 2014;114:565\u201371.","journal-title":"Circ Res"},{"key":"401_CR7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1302.017","volume":"1015","author":"H Taegtmeyer","year":"2004","unstructured":"Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci. 2004;1015:202\u201313.","journal-title":"Ann N Y Acad Sci"},{"key":"401_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1015332726303","volume":"7","author":"JJ Lehman","year":"2002","unstructured":"Lehman JJ, Kelly DP. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev. 2002;7:175\u201385.","journal-title":"Heart Fail Rev"},{"key":"401_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","volume":"90","author":"SC Kolwicz Jr","year":"2011","unstructured":"Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011;90:194\u2013201.","journal-title":"Cardiovasc Res"},{"key":"401_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15:805\u201312.","journal-title":"Cell Metab"},{"key":"401_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/138955706776073457","volume":"6","author":"A Planavila","year":"2006","unstructured":"Planavila A, Calvo RR, Vazquez-Carrera M. Peroxisome proliferator-activated receptors and the control of fatty acid oxidation in cardiac hypertrophy. Mini-Rev Med Chem. 2006;6:357\u201363.","journal-title":"Mini-Rev Med Chem"},{"key":"401_CR12","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","volume":"276","author":"ME Young","year":"2001","unstructured":"Young ME, Laws FA, Goodwin GW, Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem. 2001;276:44390\u20135.","journal-title":"J Biol Chem"},{"key":"401_CR13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.yjmcc.2010.09.021","volume":"51","author":"J Schilling","year":"2011","unstructured":"Schilling J, Kelly DP. The PGC-1 cascade as a therapeutic target for heart failure. J Mol Cell Cardiol. 2011;51:578\u201383.","journal-title":"J Mol Cell Cardiol"},{"key":"401_CR14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ptr.5083","volume":"28","author":"YX Zhou","year":"2014","unstructured":"Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28:961\u201375.","journal-title":"Phytother Res"},{"key":"401_CR15","first-page":"55","volume":"9","author":"XP Song","year":"1988","unstructured":"Song XP, Chen PP, Chai XS. Effects of puerarin on blood pressure and plasma renin activity in spontaneously hypertensive rats. Acta Pharmacol Sin. 1988;9:55\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"401_CR16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/174313209X444017","volume":"31","author":"L Gao","year":"2009","unstructured":"Gao L, Ji X, Song J, Liu P, Yan F, Gong W, et al. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol Res. 2009;31:402\u20136.","journal-title":"Neurol Res"},{"key":"401_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.29.945","volume":"29","author":"S Zhang","year":"2006","unstructured":"Zhang S, Chen S, Shen Y, Yang D, Liu X, Sun-Chi AC, et al. Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol Pharmacol Bull. 2006;29:945\u201350.","journal-title":"Biol Pharmacol Bull"},{"key":"401_CR18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/np0203887","volume":"66","author":"FL Hsu","year":"2003","unstructured":"Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod. 2003;66:788\u201392.","journal-title":"J Nat Prod"},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lfs.2006.01.016","volume":"79","author":"LP Yan","year":"2006","unstructured":"Yan LP, Chan SW, Chan ASC, Chen SL, Ma XJ, Xu HX. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 2006;79:324\u201330.","journal-title":"Life Sci"},{"key":"401_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jjcc.2013.06.008","volume":"63","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Zong J, Zhou H, Bian ZY, Deng W, Dai J, et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. J Cardiol. 2014;63:73\u201381.","journal-title":"J Cardiol"},{"key":"401_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/aps.2013.185","volume":"35","author":"G Chen","year":"2014","unstructured":"Chen G, Pan SQ, Shen C, Pan SF, Zhang XM, He QY. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1\/2, p38 and NF-kappa B pathways. Acta Pharmacol Sin. 2014;35:463\u201375.","journal-title":"Acta Pharmacol Sin"},{"key":"401_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.18433\/J3N318","volume":"18","author":"G Chen","year":"2015","unstructured":"Chen G, Cao Q, Cui X, Pan S, Shen C, Liu L. Puerarin suppresses angiotensin II-induced cardiac hypertrophy by inhibiting NADPH oxidase activation and oxidative stress-triggered AP-1 signaling pathways. J Pharm Pharmacol Sci. 2015;18:235\u201348.","journal-title":"J Pharm Pharmacol Sci"},{"key":"401_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00210-017-1353-8","volume":"390","author":"N Hou","year":"2017","unstructured":"Hou N, Cai B, Ou CW, Zhang ZH, Liu XW, Yuan M, et al. Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2017;390:535\u201345.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"401_CR24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2015.07.065","volume":"464","author":"B Liu","year":"2015","unstructured":"Liu B, Wu Z, Li Y, Ou C, Huang Z, Zhang J, et al. Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy. Biochem Biophys Res Commun. 2015;464:908\u201315.","journal-title":"Biochem Biophys Res Commun"},{"key":"401_CR25","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.12659\/MSM.895877","volume":"22","author":"X Zhang","year":"2016","unstructured":"Zhang X, Liu Y, Han Q. Puerarin attenuates cardiac hypertrophy partly through increasing Mir-15b\/195 expression and suppressing non-canonical transforming growth factor \u03b2 (Tgf\u03b2) signal pathway. Med Sci Monit. 2016;22:1516\u201323.","journal-title":"Med Sci Monit"},{"key":"401_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.118.248369","volume":"366","author":"GJ Zhao","year":"2018","unstructured":"Zhao GJ, Hou N, Cai SA, Liu XW, Li AQ, Cheng CF, et al. Contributions of Nrf2 to puerarin prevention of cardiac hypertrophy and its metabolic enzymes expression in rats. J Pharmacol Exp Ther. 2018;366:458\u201369.","journal-title":"J Pharmacol Exp Ther"},{"key":"401_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fphar.2018.00540","volume":"9","author":"SA Cai","year":"2018","unstructured":"Cai SA, Hou N, Zhao GJ, Liu XW, He YY, Liu HL, et al. Nrf2 is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats. Front Pharmacol. 2018;9:540.","journal-title":"Front Pharmacol"},{"key":"401_CR28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1440-1681.2010.05442.x","volume":"37","author":"N Hou","year":"2010","unstructured":"Hou N, Luo MS, Liu SM, Zhang HN, Xiao Q, Sun P, et al. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor alpha pathway in cultured neonatal rat cardiomyocytes. Clin Exp Pharmacol Physiol. 2010;37:1087\u201395.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"401_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/cvn001","volume":"78","author":"PJ Smeets","year":"2008","unstructured":"Smeets PJ, Teunissen BE, Willemsen PH, van Nieuwenhoven FA, Brouns AE, Janssen BJ, et al. Cardiac hypertrophy is enhanced in PPAR alpha-\/- mice in response to chronic pressure overload. Cardiovasc Res. 2008;78:79\u201389.","journal-title":"Cardiovasc Res"},{"key":"401_CR30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bpobgyn.2014.12.002","volume":"29","author":"ZA Al-Safi","year":"2015","unstructured":"Al-Safi ZA, Polotsky AJ. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol. 2015;29:548\u201353.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"401_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1262\/jrd.19002","volume":"54","author":"W Cherdshewasart","year":"2008","unstructured":"Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica by MCF-7 proliferation assay. J Reprod Dev. 2008;54:63\u20137.","journal-title":"J Reprod Dev"},{"key":"401_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cardiores.2006.08.023","volume":"73","author":"BN Finck","year":"2007","unstructured":"Finck BN. The PPAR regulatory system in cardiac physiology and disease. Cardiovasc Res. 2007;73:269\u201377.","journal-title":"Cardiovasc Res"},{"key":"401_CR33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbalip.2007.01.008","volume":"1771","author":"S Yu","year":"2007","unstructured":"Yu S, Reddy JK. Transcription coactivators for peroxisome proliferator-activated receptors. Biochim Biophys Acta. 2007;1771:936\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"401_CR34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.trsl.2015.06.003","volume":"166","author":"XP Liu","year":"2015","unstructured":"Liu XP, Gao H, Huang XY, Chen YF, Feng XJ, He YH, et al. Peroxisome proliferator-activated receptor gamma coactivator 1 \u03b1 protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway. Transl Res. 2015;166:459\u201373.","journal-title":"Transl Res"},{"key":"401_CR35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCRESAHA.111.243964","volume":"109","author":"C Riehle","year":"2011","unstructured":"Riehle C, Wende AR, Zaha VG, Pires KM, Wayment B, Olsen C, et al. PGC-1\u03b2 deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res. 2011;109:783\u201393.","journal-title":"Circ Res"},{"key":"401_CR36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2017.11.002","volume":"178","author":"W Zheng","year":"2018","unstructured":"Zheng W, Rogoschin J, Niehoff A, Oden K, Kulling SE, Xie M, et al. Combinatory effects of phytoestrogens and exercise on body fat mass and lipid metabolism in ovariectomized female rats. J Steroid Biochem Mol Biol. 2018;178:73\u201381.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"401_CR37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/gme.0b013e31817b8159","volume":"15","author":"A Paquette","year":"2008","unstructured":"Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie JM. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause. 2008;15:1169\u201375.","journal-title":"Menopause"},{"key":"401_CR38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","volume":"92","author":"AJ Gilde","year":"2003","unstructured":"Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, et al. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta\/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 2003;92:518\u201324.","journal-title":"Circ Res"},{"key":"401_CR39","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","volume":"105","author":"PM Barger","year":"2000","unstructured":"Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest. 2000;105:1723\u201330.","journal-title":"J Clin Invest"},{"key":"401_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmet.2007.03.007","volume":"5","author":"CR Dufour","year":"2007","unstructured":"Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007;5:345\u201356.","journal-title":"Cell Metab"},{"key":"401_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115\u201324.","journal-title":"Cell"},{"key":"401_CR42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","volume":"95","author":"JM Huss","year":"2004","unstructured":"Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res. 2004;95:568\u201378.","journal-title":"Circ Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0401-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:17Z","timestamp":1684616597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0401-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0401-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}